Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6603)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 9, 2022 (publication date) through Mar 11, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Swarnakar R, Roy SS, Yadav SL. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World J Exp Med 2022; 12(6): 108-110 [PMID: 36560976 DOI: 10.5493/wjem.v12.i6.108] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Swarnakar R, Roy SS, Yadav SL. Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis. World J Exp Med 2022; 12(6): 108-110 [PMID: 36560976 DOI: 10.5493/wjem.v12.i6.108] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v12/i6/108.htm |
| Number | Citing Articles |
| 1 |
Marco Zeppieri. Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis. World Journal of Experimental Medicine 2023; 13(4): 95-98 doi: 10.5493/wjem.v13.i4.95
Abstract(1227) |
Core Tip(1142) |
Full Article(HTML)(2863)
|
Full Article with Cover (PDF)-553K(190)
|
Full Article (Word)-103K(50)
|
Audio-345K(10)
|
Peer-Review Report-218K(142)
|
Answering Reviewers-111K(151)
|
Full Article (PDF)-359K(191)
|
Full Article (XML)-43K(174)
|
Times Cited (0)
|
Total Visits (10009)
|
Open
|